Madrigal Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
PTLAPortola Pharmaceuticals, Inc. 0.56%17.956.5%$165.07m
HZNPHorizon Therapeutics Plc 4.06%50.736.5%$146.36m
CTLTCatalent, Inc. 0.81%77.522.3%$138.66m
MYOKMyoKardia, Inc. 2.14%102.291.8%$130.35m
BHCBausch Health Cos., Inc. -0.75%18.440.0%$119.26m
VRXValeant Pharmaceuticals International, Inc. -0.75%18.4414.1%$108.50m
UTHRUnited Therapeutics Corp. 2.57%117.9514.3%$75.18m
JAZZJazz Pharmaceuticals Plc 0.45%119.322.4%$60.64m
ICPTIntercept Pharmaceuticals, Inc. -0.66%72.2616.8%$59.67m
AMRNAmarin Corp. Plc 0.44%6.861.6%$57.99m
GWPHGW Pharmaceuticals Plc -2.16%122.756.2%$55.98m
ARGXargenx SE 3.60%219.300.0%$52.90m
AXSMAxsome Therapeutics, Inc. 0.60%76.981.9%$50.67m
PRGOPerrigo Co. Plc -0.42%54.806.8%$45.78m
ICLRICON plc 1.72%168.454.3%$44.44m

Company Profile

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.